| Members |
targetComponentId |
| Verruca plana |
Plane wart |
| Verruca vulgaris |
Verruca vulgaris |
| dermatos orsakad av ryggradsdjur |
Animal-induced dermatosis |
| Vesicular stomatitis |
Vesicular stomatitis |
| vesikulär stomatit-virus, Cocal |
Cocal virus (organism) |
| Vespa |
Vespa |
| Vestibular neuronitis |
Epidemic vertigo |
| Veterinary nursing AND/OR grooming procedure |
Nursing procedure |
| vibration av livmoderhalsen |
Uterine cervix manipulation |
| Vibration of cervix |
Uterine cervix manipulation |
| Vibrio anguillarium |
Listonella anguillarum (organism) |
| Vibrio carchariae |
Vibrio harveyi |
| Vibrio costicola |
Salinivibrio costicola |
| Vibrio damsela |
Photobacterium damselae (organism) |
| Vibrio fischeri |
Aliivibrio fischeri |
| Vibrio hollisae |
Grimontia hollisae (organism) |
| Vibrio marinus |
Moritella marina (organism) |
| Vibrio trachuri |
Vibrio harveyi |
| Vibrionaceae ichthyoenteri |
Vibrio ichthyoenteri (organism) |
| trakasserar andra |
Abusive behavior towards people (finding) |
| Villous adenoma |
Villous adenoma (morphologic abnormality) |
| vinblastinsulfat 30 mg/30 ml, injektionsvätska, lösning |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
| vinblastinsulfat 30 mg/30ml, för infusion |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
| vinblastinsulfat 50 mg/50 ml, infusionsvätska, lösning |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
| vinblastinsulfat 50 mg/50 ml, för infusion |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
| Vinca alkaloid |
Vinca alkaloid |
| vinkristin 1 mg, pulver och vätska till injektionslösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristin 1 mg, pulver till injektionsvätska, lösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristin 2 mg, pulver och vätska till injektionslösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristin 2 mg, pulver till injektionsvätska, lösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristin 5 mg, pulver och vätska till injektionslösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristin 5 mg, pulver till injektionsvätska, lösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristinsulfat 10 mg/50 ml, infusionsvätska, lösning |
Vincristine only product in parenteral dose form |
| vinkristinsulfat 10 mg/50 ml, för infusion |
Vincristine only product in parenteral dose form |
| vinkristinsulfat 5 mg/50 ml, infusionsvätska, lösning |
Vincristine only product in parenteral dose form |
| vinkristinsulfat 5 mg/50 ml, för infusion |
Vincristine only product in parenteral dose form |
| vinorelbin 10 mg/1 ml, intravenös vätska, lösning |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| vinorelbin 50 mg/5 ml, intravenös vätska, lösning |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Vinorelbine tartrate 10mg/mL injection solution 1mL vial |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Vinorelbine tartrate 10mg/mL injection solution 5mL vial |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Vinorelbine tartrate 10mg/mL solution |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Viper type C oncovirus |
Viper retrovirus (organism) |
| Vipera |
Subfamily Viperinae (organism) |
| Vipera persica |
Pseudocerastes persicus |
| Viral gastroenteritis due to other viral agents |
Viral gastroenteritis |
| Viral hepatitis, non-A, non-B |
Viral hepatitis C |
| virusinfektion, indelning efter lokalisation |
Viral disease |
| Visually threatening diabetic retinopathy |
Visually threatening diabetic retinopathy |
| Vitamin A deficiency with other ocular manifestations |
Vitamin A deficiency with ocular manifestation |
| allergi mot B12-vitamin |
Allergy to vitamin B12 and/or vitamin B12 derivative (finding) |
| Vitamin B>12< deficiency neuropathy |
Subacute combined degeneration of spinal cord |
| D3-vitaminmetabolit |
Vitamin D analogue |
| Vitamin P preparation |
Bioflavonoid |
| Vitropression |
Diascopy procedure |
| Vocal |
Vocal resonance |
| röststörning orsakad av transsexualism |
Speech and language disorder |
| beroende av flyktigt inhalationsmedel med nuvarande användning |
Inhalant dependence |
| volymstyrd ventilation |
Continuous mandatory ventilation (regime/therapy) |
| Vomiting |
Vomiting (disorder) |
| kräkning förenat med andra psykiska störningar |
Psychogenic vomiting |
| Vomiting disorder |
Vomiting (disorder) |
| fynd som rör TNM-stadieindelning av tumör i vulva |
American Joint Committee on Cancer allowable value |
| Vulva excision |
Vulvectomy |
| Vulvar ulceration |
Ulceration of vulva |
| W plasty NEC |
W-plasty of skin |
| Waardenburg syndrome, types I and II |
Waardenburg syndrome |
| Wagstaffes fraktur |
Avulsion fracture of anterior fibula (disorder) |
| warfarin 2 mg/ml, pulver till injektionsvätska, lösning |
Warfarin sodium 5 mg powder for solution for injection vial |
| varm miljö |
Warm environment |
| Wart snake |
Family Acrochordidae (organism) |
| Washing |
Action |
| Washing of animal |
Bathing patient |
| vatten till injektion, påse 100 ml |
Water only product in parenteral dose form |
| vatten till injektion, ampull 10 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
| vatten till injektion, påse 1000 ml |
Water only product in parenteral dose form |
| vatten till injektion, ampull 1 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
| vatten till injektion, ampull 20 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
| vatten till injektion, ampull 2 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
| vatten till injektion, ampull 50 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
| vatten till injektion, ampull 5 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
| Watkins-Wertheims operation av livmodern |
Surgical repair of prolapsed uterus |
| Weakening of extraocular muscle |
Strabismus surgery |
| påbörjad avvänjning från mekanisk andningshjälp |
Weaning from mechanically assisted ventilation commenced |
| frakturtyper enligt Weber |
Fracture configurations |
| frakturtyp A enligt Weber |
Weber type A fracture (morphologic abnormality) |
| frakturtyp B enligt Weber |
Weber type B fracture |
| frakturtyp C enligt Weber |
Weber type C fracture |
| kilosteotomi, aktivitet |
Incision - action |
| Weekly |
Weekly (qualifier value) |
| Weeksella zoohelcum |
Bergeyella zoohelcum |
| viktsymtom |
Weight finding |
| Weight symptom |
Weight finding |
| Weight symptom NOS |
Weight finding |
| Weight symptom NOS |
Weight finding |
| Weissenbacher-Zweymullers syndrom |
Stickler syndrome type 3 (disorder) |
| rullstolsburen |
Able to mobilise using wheelchair |
| vit färg |
White color (qualifier value) |
| White spot lesions of teeth |
Incipient enamel caries |
| kroppen, som helhet |
Entire body as a whole |
| bröst som helhet |
Entire breast |
| framfot, som helhet |
Entire forefoot region of foot (body structure) |